Pfizer–BioNTech’s Omicron- adapted COVID-19 vaccine receives CHMP recommendation for EU market
GLOBAL — Pfizer Inc. and BioNTech SE have announced that the European Medicines Agency’s...
Read MoreSelect Page
Sep 27, 2024
GLOBAL — Pfizer Inc. and BioNTech SE have announced that the European Medicines Agency’s...
Read MoreOct 19, 2023
AFRICA — German mRNA vaccine maker BioNTech has joined forces with vaccine manufacturing...
Read MoreJun 13, 2023
GERMANY —German biotechnology company BioNTech is currently embroiled in a legal dispute as it...
Read MoreMay 29, 2023
BELGIUM — The European Union (EU) and pharmaceutical companies Pfizer and BioNTech have announced...
Read MoreMay 14, 2023
GERMANY — BioNTech has chosen to sever ties with Matinas BioPharma after an oral mRNA delivery...
Read MoreApr 4, 2023
GERMANY — BioNTech has entered into a partnership with DualityBio, a move that will enable both...
Read MoreFeb 3, 2023
GERMANY – BioNTech SE has completed the US$43 million (€40m) construction of its first proprietary...
Read MoreJan 12, 2023
GERMANY — BioNTech SE, a German-based immunotherapy company, has agreed to acquire British...
Read MoreJan 7, 2023
GERMANY – BioNTech SE has signed a collaboration agreement with the Government of the United...
Read MoreDec 20, 2022
TAIWAN — Germany’s BioNTech is planning to set up a clinical trial hub in Taiwan for mRNA-based...
Read More